PubMed · 15952708
Commentary. Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.
Abstract
The source did not provide an abstract. Follow the original record for more information.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Russell Samson. 2005. Commentary. Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.. https://pubmed.ncbi.nlm.nih.gov/15952708/
Cite the original work for its findings. Save a collection to share your selection of sources.